Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Advinus And Orchid Sign Discovery Deals

October 6, 2008 | A version of this story appeared in Volume 86, Issue 40

Two Indian firms have entered drug discovery and development agreements with Western drug companies. Advinus Therapeutics will work with Ortho-McNeil-Janssen Pharmaceuticals to develop drug candidates for various targets. Advinus says it will receive an up-front payment and possible milestone payments of up to $247 million upon successful development of two compounds. Meanwhile, Orchid Chemicals & Pharmaceuticals will work with Merck & Co. on novel agents for bacterial and fungal infections. Orchid says it will get an up-front payment and possible milestone payments of more than $100 million.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.